No definition available.
Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)
C3_PROSTATE_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
4 out of 7 registries used, show all original rules. |
20966 |
4. Check minimum number of eventsNone |
20966 |
5. Include endpointsNone |
20966 |
6. Filter based on genotype QC (FinnGen only) |
20966 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 20966 | - | 20966 |
| Unadjusted period prevalence (%) | 9.24 | - | 9.24 |
| Median age at first event (years) | 69.21 | - | 69.21 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3955
- Matched controls
- 32975
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L02BB03
ATC
bicalutamide; oral
+∞
323.0
444
*
L02BX02
ATC
degarelix; parenteral
+∞
323.0
342
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
26.4
323.0
1553
787
XX3DW
NOMESCO Finland
Time consuming IT work
16.3
323.0
1064
726
ZXC96
NOMESCO Finland
Robot assisted procedure
295.5
323.0
1083
42
C61
ICD-10 Finland
Malignant neoplasm of prostate
4503599627370496.0
323.0
3891
11
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
10.5
323.0
1910
2697
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
323.0
420
*
Y77
ICPC
Malignant neoplasm prostate
3474.1
323.0
709
*
TKE00
NOMESCO Finland
Needle biopsy of prostate
17.7
323.0
566
308
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
25.4
323.0
698
276
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
79.7
323.0
2276
551
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
149.0
323.0
619
41
WF002
NOMESCO Finland
Radical radiotherapy
841.5
323.0
1099
15
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
323.0
1678
*
XKD00
NOMESCO Finland
Uroflowmetry
12.2
323.0
2312
3406
NK6AN
NOMESCO Finland
Total body bone isotope imaging
357.1
323.0
525
14
116
Kela drug reimbursment
Prostate cancer
+∞
323.0
1434
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
323.0
877
*
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
6.7
323.0
1193
1987
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
5527.7
323.0
578
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
6043.8
323.0
623
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
323.0
3927
*
KC1GB
NOMESCO Finland
Cystography with X-ray
289.6
323.0
375
12
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.6
323.0
1790
4982
H02AB02
ATC
dexamethasone; systemic
33.3
304.9
426
119
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
709.2
301.1
314
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
359.0
299.5
319
8
G04BE03
ATC
sildenafil; oral
41.2
297.9
397
89
JN4BD
NOMESCO Finland
Extensive body CT
8.9
297.6
706
783
KE1DG
NOMESCO Finland
Very extensive MRI of prostate
32.3
289.9
408
117
J01EA01
ATC
trimethoprim; systemic
7.0
287.2
805
1155
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
447.3
282.8
299
6
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
279.5
284
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
279.5
284
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2312.1
261.2
268
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
803.7
259.2
270
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2274.1
257.2
264
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
255.6
260
*
G04BE01
ATC
alprostadil; parenteral, urethral
28.7
253.2
367
117
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
237.7
242
*
KE1BG
NOMESCO Finland
MRI of prostate
37.9
229.4
311
74
JN4AD
NOMESCO Finland
Body CT examination
9.4
225.3
511
511
KDE20
NOMESCO Finland
Removal of foreign body from urethra
71.6
223.9
272
34
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
162.2
213.0
238
13
A04AA02
ATC
granisetron; systemic, transdermal
279.4
203.4
220
7
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
26.7
195.8
289
97
L02BB04
ATC
enzalutamide; oral
+∞
195.0
199
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
194.0
198
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
1595.5
184.9
191
*
L02AE04
ATC
triptorelin; parenteral
+∞
181.2
185
*
KE1CG
NOMESCO Finland
Extensive MRI of prostate
43.8
173.2
228
46
130
Kela drug reimbursment
Malignant tumour
+∞
169.3
173
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
24.8
168.7
254
91
XJH00
NOMESCO Finland
Transanal ultrasonography
5.7
165.0
530
868
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
164.6
1312
4790
KEB00
NOMESCO Finland
Biopsy of prostate
38.2
163.4
221
51
B01AB05
ATC
enoxaparin; parenteral
2.8
157.5
1308
4873
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
156.5
160
*
M05BX04
ATC
denosumab; parenteral
22.8
153.6
237
92
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.3
153.5
954
2908
WZC30
NOMESCO Finland
Teaching
3.9
147.9
715
1775
G04CA02
ATC
tamsulosin; oral
2.5
146.4
1599
6935
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
39.0
145.6
196
44
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
143.7
147
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
141.5
561
1152
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.7
136.7
273
208
L03AA13
ATC
pegfilgrastim; parenteral
1191.4
131.7
137
*
UKC02
NOMESCO Finland
Cystoscopy
3.2
131.2
837
2565
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
1181.2
130.8
136
*
ZX080
NOMESCO Finland
Image guided radiotherapy
576.6
127.0
134
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
123.0
126
*
N40
ICD-10 Finland
Hyperplasia of prostate
2.4
122.0
1447
6394
TKE10
NOMESCO Finland
Puncture of prostate
229.9
121.5
133
5
J01MA02
ATC
ciprofloxacin; systemic
2.3
121.3
1742
8454
N39.3
ICD-10 Finland
Stress incontinence
85.7
117.1
139
14
WX402
NOMESCO Finland
General anaesthesia
3.0
115.8
820
2672
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
271.0
115.2
125
*
L02BX03
ATC
abiraterone; oral
+∞
115.2
118
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
113.2
116
*
G04BE30
ATC
drugs used in erectile dysfunction - combinations
338.9
110.8
119
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
259.4
110.3
120
*
OAB42
NOMESCO Finland
Guidance related to known health problem
120.5
109.9
126
9
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
107.3
110
*
TQW40
NOMESCO Finland
Remowal of suture of skin
4.1
106.3
465
1035
WF004
NOMESCO Finland
Palliative radiotherapy
933.2
104.3
109
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
13.2
95.8
180
119
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
95.5
98
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
218.3
93.0
102
*
3054
Kela drug reimbursment
NA
+∞
92.6
95
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
92.6
95
*
1523
Kela drug reimbursment
NA
+∞
91.6
94
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
89.7
92
*
Z51.5
ICD-10 Finland
Palliative care
13.2
87.4
164
108
N02BE01
ATC
paracetamol; systemic, rectal
2.2
82.1
3263
22499
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
705.5
79.0
83
*
Z51.0
ICD-10 Finland
Radiotherapy session
688.1
77.0
81
*
TKC52
NOMESCO Finland
Patient education concerning pelvic floor contraction exercises
174.4
73.7
82
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
224.4
72.1
79
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
72.1
74
*
JN4CD
NOMESCO Finland
Very extensive body CT
7.6
69.1
174
199
ZX112
NOMESCO Finland
Subcutaneous
14.1
69.0
125
76
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
6.8
67.4
182
231
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
65.2
67
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
65.2
67
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
575.4
64.4
68
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
290.6
63.9
69
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
63.3
65
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
60.5
1780
10435
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
41.9
60.0
79
16
A04AA01
ATC
ondansetron; systemic, rectal
7.8
59.8
147
162
G04BD12
ATC
mirabegron; oral
3.0
57.3
373
1114
R31
ICD-10 Finland
Unspecified haematuria
2.6
55.4
448
1529
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
54.4
1564
9003
A79
ICPC
Malignancy NOS
246.6
53.3
58
*
Y06
ICPC
Prostate symptom/complaint
4.0
53.0
228
492
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
16.0
52.4
90
48
L02AE03
ATC
goserelin; implant
454.9
50.8
54
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
38.4
50.8
68
15
U04
ICPC
Incontinence urine
6.5
50.6
140
184
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
50.6
52
*
TKC20
NOMESCO Finland
Catheterisation of bladder
3.1
50.3
304
860
ZX050
NOMESCO Finland
Stereotactic radiotherapy
45.9
50.3
65
12
N02AA05
ATC
oxycodone; systemic
2.6
48.8
413
1441
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
47.6
49
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
20.9
47.4
74
30
G03HA01
ATC
cyproterone; systemic
31.1
47.1
66
18
KCC10
NOMESCO Finland
Cystoprostatectomy
215.5
46.6
51
*
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
67.7
46.1
56
7
KD1GB
NOMESCO Finland
Uretrocystogpaphy with X-ray
39.7
46.0
61
13
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
45.7
47
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
45.7
47
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
45.7
47
*
L01BC06
ATC
capecitabine; oral
+∞
45.7
47
*
B01AB10
ATC
tinzaparin; parenteral
3.6
45.0
220
530
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
+∞
43.8
45
*
KDG43
NOMESCO Finland
Transobturatorial sling urethrocystopexy
+∞
43.8
45
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
43.8
45
*
R33
ICD-10 Finland
Retention of urine
2.7
43.4
333
1096
XX1AD
NOMESCO Finland
Other CT-examination
73.2
43.3
52
6
KE1DR
NOMESCO Finland
Prostate metabolic PET with CT
+∞
42.8
44
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
103.4
42.4
49
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
369.2
41.2
44
*
L03AA02
ATC
filgrastim; parenteral
47.8
39.9
51
9
A04AD12
ATC
aprepitant; systemic
+∞
39.9
41
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
38.4
395
1520
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
37.9
39
*
XKG00
NOMESCO Finland
Artificial induction of erection
29.8
37.6
53
15
G04CA01
ATC
alfuzosin; oral
1.8
37.3
809
4166
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
326.5
36.4
39
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
34.4
36.0
49
12
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
36.0
37
*
KDW96
NOMESCO Finland
Other operations on urethra
72.5
35.8
43
5
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.0
35.6
153
330
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
47.4
35.2
45
8
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
309.4
34.4
37
*
J01MA12
ATC
levofloxacin; systemic
1.8
34.0
649
3192
XX7FT
NOMESCO Finland
Radioyttrium therapy with connected antibody
+∞
34.0
35
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
34.0
35
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
109.4
34.0
39
*
TKC22
NOMESCO Finland
Catheterisation instruction
4.2
33.7
135
273
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
300.9
33.5
36
*
WVA20
NOMESCO Finland
Medicine administration
4.6
33.2
123
230
G04BD08
ATC
solifenacin; oral
3.1
32.5
195
548
Z12.5
ICD-10 Finland
Special screening examination for neoplasm of prostate
8.6
32.5
74
73
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
32.1
33
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
48.1
31.4
40
7
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
11.8
31.1
60
43
2BX02
NOMESCO Finland
NA
+∞
31.1
32
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
31.1
32
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
31.1
32
*
G04BE09
ATC
vardenafil; oral
46.9
30.5
39
7
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
46.9
30.5
39
7
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
266.8
29.6
32
*
R86.1
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of hormones
10.7
28.3
57
45
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
28.2
29
*
A06AH03
ATC
naloxegol; oral
19.5
27.9
44
19
R74.9
ICD-10 Finland
Abnormal level of unspecified serum enzyme
10.7
27.9
56
44
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
253.6
27.7
30
*
ZXC20
NOMESCO Finland
Use of chemical agents
8.9
27.0
60
57
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
26.2
27
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.6
26.1
80
122
WW500
NOMESCO Finland
Blood transfusion
4.4
25.6
98
191
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
25.3
26
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
25.3
26
*
WF099
NOMESCO Finland
Other radiotherapy
25.2
24.7
36
12
KED22
NOMESCO Finland
Transurethral resection of prostate
2.4
24.6
223
803
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
10.3
24.5
50
41
WX704
NOMESCO Finland
Intubation
2.2
24.3
254
977
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
5.4
24.0
75
117
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
23.8
244
932
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
23.3
24
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
209.8
22.9
25
*
XKD03
NOMESCO Finland
Urethral pressure profilometry
5.2
22.5
72
116
1CD02
NOMESCO Finland
NA
+∞
22.3
23
*
ZX022
NOMESCO Finland
LDR radiotherapy within tissue
+∞
22.3
23
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
22.1
656
3635
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
72.7
21.8
26
*
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
5.2
21.7
70
114
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
21.4
22
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
21.4
22
*
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
19.8
21.2
33
14
PJA12
NOMESCO Finland
Sentinel node biopsy
192.8
21.0
23
*
KE1DM
NOMESCO Finland
Very extensive MRI of prostate (more than 1.5 T)
69.9
20.9
25
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
20.4
21
*
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
5.7
20.2
60
89
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
184.3
20.0
22
*
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
18.6
19.6
31
14
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
175.9
19.1
21
*
WX110
NOMESCO Finland
Local anesthesy
1.4
18.9
2340
16994
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
18.8
270
1189
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
18.5
173
634
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
18.4
19
*
N30.4
ICD-10 Finland
Irradiation cystitis
+∞
18.4
19
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
18.0
509
6050
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
+∞
17.5
18
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
17.5
18
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
17.5
18
*
R4110
NOMESCO Finland
Physiotherapy
1.5
17.4
825
5054
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
17.4
247
1084
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
18.9
17.2
27
12
KE1AE
NOMESCO Finland
Percutaneous utlrasound examination fo prostata
8.2
17.1
39
40
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
17.0
318
1537
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.9
16.9
106
308
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.0
16.7
102
293
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
25.1
16.7
24
8
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
79.6
16.2
19
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.2
16.1
63
127
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
15.8
316
1558
XX1XQ
NOMESCO Finland
Other SPECT-CT
+∞
15.5
16
*
OAB77
NOMESCO Finland
Discussion on exercise habits and instruction concerning use of sports and fitness services
+∞
15.5
16
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
15.5
16
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
53.0
15.4
19
*
NK6SN
NOMESCO Finland
Bone SPECT
75.4
15.3
18
*
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
23.0
15.0
22
8
TJF80
NOMESCO Finland
Ostomy education
10.6
14.7
29
23
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
14.6
15
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
133.9
14.3
16
*
R39.1
ICD-10 Finland
Other difficulties with micturition
2.2
14.1
141
536
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
14.1
1388
9570
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
14.1
522
3025
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
37.6
13.8
18
*
ZX100
NOMESCO Finland
Oral
4.7
13.7
47
84
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
13.6
14
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
13.6
14
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
13.6
14
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
13.6
14
*
XKC03
NOMESCO Finland
Water cystometry
2.9
13.5
82
235
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.5
13.5
111
381
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
125.5
13.4
15
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
125.5
13.4
15
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.2
13.3
143
562
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
30.1
13.2
18
5
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
6.4
13.2
35
46
KA3EB
NOMESCO Finland
Antegrade pyelography
8.4
12.6
28
28
C61, D400
ICD-10 Finland
NA
+∞
12.6
13
*
KE2KT
NOMESCO Finland
Marker implantation in prostate under radiological guidance
+∞
12.6
13
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
12.6
13
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
12.6
13
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.6
12.6
58
137
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
62.8
12.5
15
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
12.4
188
847
N99.1
ICD-10 Finland
Postprocedural urethral stricture
8.1
12.4
28
29
JN6AD
NOMESCO Finland
CT of torso and neck
7.6
12.3
29
32
R50.9
ICD-10 Finland
Fever, unspecified
1.6
12.3
342
1850
R86.9
ICD-10 Finland
Abnormal findings in specimens from male genital organs, unspecified abnormal finding
13.5
12.0
21
13
OAB75
NOMESCO Finland
Nutritional guidance related to maintaining health
41.8
11.8
15
*
WVA30
SPAT
NA
2.3
11.7
112
418
D07.5
ICD-10 Finland
Carcinoma in situ: Prostate
+∞
11.6
12
*
KE2JT
NOMESCO Finland
Demanding radiation source placement in prostate under ultrasound guidance
+∞
11.6
12
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
11.6
12
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
11.6
12
*
XX7AT
NOMESCO Finland
Radiation therapy with Radium-223
+∞
11.6
12
*
U76
ICPC
Malignant neoplasm of bladder
108.7
11.5
13
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
5.2
11.4
35
56
ZX136
NOMESCO Finland
Intravesicalis
11.7
11.3
21
15
SPAT1262
SPAT
Handing over of treatment supplies
1.4
11.2
630
3954
U08
ICPC
Urinary retention
2.9
11.1
68
197
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.5
11.1
93
1495
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
11.0
11.0
21
16
KCW96
NOMESCO Finland
Other operations on bladder
8.4
10.9
24
24
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
10.7
261
1365
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
54.3
10.7
13
*
U77
ICPC
Malignant neopl urinary tract other
+∞
10.7
11
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
10.7
11
*
KDK10
NOMESCO Finland
Implantation of artificial urinary sphincter around bulbar urethra
+∞
10.7
11
*
WB211
NOMESCO Finland
Neoadjuvant hormone therapy of malignancy
+∞
10.7
11
*
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
+∞
10.7
11
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.2
10.7
111
430
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.2
10.6
11
444
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
11.2
10.6
20
15
C90.0
ICD-10 Finland
Multiple myeloma
100.3
10.6
12
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
100.3
10.6
12
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
100.3
10.6
12
*
103
Kela drug reimbursment
Diabetes, insulin-treated
0.7
10.5
674
7095
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
10.4
87
305
G04CB02
ATC
dutasteride; oral
1.6
10.3
249
1298
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.7
10.2
196
958
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
20.9
10.1
15
6
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
4.8
10.0
33
58
KA1FN
NOMESCO Finland
Isotope renography
5.7
9.9
28
41
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
9.9
447
4948
KE2AT
NOMESCO Finland
Cytologoy of prostata with ultrasound guidance
50.1
9.8
12
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
6.9
9.8
24
29
L02BB01
ATC
flutamide; oral
+∞
9.7
10
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.7
10
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
9.7
10
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
9.7
10
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
9.7
10
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
91.9
9.6
11
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
14.9
9.6
16
9
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.5
9.6
338
1933
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.6
9.6
68
219
N48.4
ICD-10 Finland
Impotence of organic origin
1.9
9.4
137
613
WX600
NOMESCO Finland
Single shot through catheter
6.5
9.4
24
31
N05AA02
ATC
levomepromazine; systemic
0.4
9.2
51
938
ZX120
NOMESCO Finland
Intravenous
1.7
9.2
200
1016
N35.9
ICD-10 Finland
Urethral stricture, unspecified
2.8
9.0
57
171
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
6.4
8.9
23
30
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
7.3
8.9
21
24
B01AC04
ATC
clopidogrel; oral
0.7
8.9
304
3530
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.8
8.8
668
6898
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
8.7
9
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
8.7
9
*
D63.0
ICD-10 Finland
Anaemia in neoplastic disease
+∞
8.7
9
*
ZX137
NOMESCO Finland
To penis
+∞
8.7
9
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
8.7
9
*
4194
NOMESCO Finland
NA
83.6
8.7
10
*
WF001
NOMESCO Finland
Preoperative radiotherapy
83.6
8.7
10
*
N30.9
ICD-10 Finland
Cystitis, unspecified
2.6
8.7
63
206
N05AX08
ATC
risperidone; systemic
0.5
8.6
58
995
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.3
8.6
16
464
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.2
8.5
12
403
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
5.6
8.4
24
36
U06
ICPC
Haematuria
2.6
8.4
61
200
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.5
8.3
69
1105
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.3
8.1
22
534
N05AC02
ATC
thioridazine; oral
0.2
8.1
11
378
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
20.1
8.1
12
5
OAA41
NOMESCO Finland
Health check based on individual needs
41.8
8.0
10
*
A10AA02
ATC
NA
0.3
7.9
19
487
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.0
7.9
104
449
WW200
SPAT
NA
0.7
7.8
180
2246
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
75.2
7.8
9
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
75.2
7.8
9
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
75.2
7.8
9
*
N42.8
ICD-10 Finland
Other specified disorders of prostate
4.1
7.8
29
59
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
7.8
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.8
8
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
7.8
8
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.8
8
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
7.8
8
*
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
7.8
8
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
7.8
8
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
7.8
8
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
7.8
8
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.8
8
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
+∞
7.8
8
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
7.8
8
*
5BX04
NOMESCO Finland
NA
+∞
7.8
8
*
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
8.9
7.7
16
15
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
23.0
7.7
11
*
ECB20
NOMESCO Finland
Oral alveoplasty
3.1
7.7
40
107
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
7.7
3379
26997
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
16.7
7.6
12
6
N03AG01
ATC
valproic acid; systemic, rectal
0.5
7.6
61
992
P72
ICPC
Schizophrenia
0.2
7.6
10
349
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
14.3
7.3
12
7
SPAT1153
SPAT
Removal of sutures
1.2
7.2
923
6465
WX320
NOMESCO Finland
Spinalanesthesy
1.3
7.2
615
4096
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
0.5
7.2
64
1004
A10BA02
ATC
metformin; oral
0.8
7.2
735
7345
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
3.4
7.1
33
82
TQX05
NOMESCO Finland
Skin puncture, unspecified location
8.4
7.1
15
15
U99
ICPC
Urinary disease other
4.5
7.0
24
45
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
6.8
7.0
17
21
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
6.8
7.0
17
21
U28
ICPC
Limited function/disability (U)
3.8
6.9
28
62
N05AB03
ATC
perphenazine; systemic, rectal
0.4
6.9
33
633
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
0.5
6.8
53
868
C07AB07
ATC
bisoprolol; oral
0.8
6.8
1196
11339
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
6.8
7
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
6.8
7
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
6.8
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
6.8
7
*
8000/3-C61.9
ICD-O-3
Neoplasm, malignant of prostate gland
+∞
6.8
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.8
7
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
6.8
7
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.8
7
*
Y78
ICPC
Malign neopl male genital other
+∞
6.8
7
*
Y77
ICD-10 Finland
Ophthalmic devices associated with adverse incidents
+∞
6.8
7
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.8
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.8
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
6.8
7
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
6.8
205
1138
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
2.9
6.8
39
112
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
6.8
142
716
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.9
6.7
87
376
R32
ICD-10 Finland
Unspecified urinary incontinence
3.2
6.7
33
86
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
0.3
6.7
15
395
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
6.7
56
200
N30.0
ICD-10 Finland
Acute cystitis
1.7
6.6
121
588
A10AA01
ATC
NA
0.3
6.6
17
422
KH1AD
NOMESCO Finland
CT of urinary organs
1.7
6.6
129
637
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
6.6
1251
9124
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
0.4
6.6
24
516
U13
ICPC
Bladder symptom/complaint other
2.7
6.6
43
134
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.8
6.6
117
564
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
3.1
6.6
34
92
N05AH02
ATC
clozapine; systemic
0.3
6.5
11
334
N41.0
ICD-10 Finland
Acute prostatitis
1.7
6.5
116
560
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.1
6.5
11
7
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.2
6.5
32
84
WX290
NOMESCO Finland
Other blockade of nerve
1.2
6.3
1388
10259
UJF32
NOMESCO Finland
Coloscopy
1.3
6.3
637
4334
J01CA08
ATC
pivmecillinam; oral
1.8
6.2
106
502
WX872
NOMESCO Finland
Intensive care
0.6
6.2
87
1210
G04BE08
ATC
tadalafil; oral
8.4
6.2
13
13
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
18.8
6.1
9
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
2.9
6.0
35
102
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
7807
32278
1.96
314.68
7.7
4.2
11.7
13.5
umol/l
31.29
7502
30441
10602
39966
3.13
307.65
5.2
3.7
288.6
603.1
e6/l
0.73
207
764
6542
23343
2.23
307.65
4.6
3.5
77.3
97.9
e6/l
0.96
5399
17235
4539
14327
2.30
307.65
3.0
2.5
2.5
2.7
e6/l
0.79
4063
12441
4035
8119
3.73
307.65
2.2
2.2
8.0
14.9
nmol/l
307.65
3462
7178
8029
31235
2.19
307.65
4.8
2.7
1.1
0.7
ug/l
43.49
6367
21265
6275
20909
2.40
307.65
4.2
3.1
139.3
115.3
e6/l
0.32
5246
16189
5629
19003
2.26
307.65
3.9
3.0
0.3
0.5
e6/l
7.29
4584
14259
11302
49429
2.61
307.65
9.7
5.6
82.4
76.0
u/l
17.19
10908
45946
10200
44444
2.23
307.65
8.0
3.7
15.3
24.0
%
307.65
7212
21418
7283
24857
2.50
307.65
4.0
3.2
—
0.7
—
0
8
7323
28705
2.06
307.65
4.5
3.8
—
—
—
0
0
12418
55573
3.20
307.65
12.0
3.9
10.0
2.2
ug/l
21.67
11090
50138
5020
18004
2.02
298.29
4.5
2.1
2.3
2.3
mmol/l
5.50
4486
15072
566
481
7.30
297.50
2.4
1.3
23.5
19.5
ug/l
0.67
554
469
1612
3509
2.97
283.54
3.9
1.5
23.4
8.9
ug/l
1.54
1332
2666
3448
11014
2.15
273.57
3.9
2.8
0.6
0.8
e6/l
2.88
2178
6180
385
255
9.27
240.96
2.8
1.8
6.3
5.5
nmol/l
0.17
380
247
3480
11959
1.98
220.57
3.6
2.6
0.8
0.9
e6/l
2.20
2198
7067
7096
31605
1.67
181.40
8.1
6.6
1.2
1.2
mmol/l
2.63
5910
26634
6489
28785
1.63
161.81
7.0
6.3
1.2
1.2
mmol/l
4.80
5880
25757
7427
34174
1.61
158.57
9.5
6.4
4.3
4.5
e9/l
6.29
6491
29249
3735
14625
1.71
146.49
2.6
2.3
—
—
—
0
0
6131
27269
1.60
146.32
5.1
4.2
34.5
35.1
g/l
10.25
5671
25073
8484
41452
1.54
126.74
4.9
5.1
6.9
7.0
mmol/l
10.91
8061
38932
6678
31127
1.53
121.97
10.3
11.4
1.3
1.4
inr
4.95
1996
8442
1393
4179
2.10
121.03
3.6
2.6
0.2
0.3
e6/l
2.54
1373
4118
2576
10024
1.66
97.67
3.6
2.0
2.5
2.4
mmol/l
14.90
2262
8450
2065
7571
1.74
97.33
4.7
2.7
252.8
241.6
u/l
1.74
1967
7051
6533
31530
1.44
89.72
3.9
3.3
0.0
0.0
estimate
2.03
1469
5096
6435
31087
1.43
86.91
5.1
4.3
0.0
0.0
estimate
0.50
1535
5543
554
1277
2.66
85.34
3.0
2.0
907.4
112.1
u/ml
1.95
466
1056
6447
31280
1.42
83.97
3.8
3.3
0.0
0.0
estimate
0.50
1496
5340
11927
65046
1.53
80.04
18.3
14.4
29.9
27.5
mg/l
9.28
10009
51949
11547
62552
1.50
79.85
19.5
13.4
75.3
76.5
ml/min/173m2
8.04
10193
51178
5125
24441
1.40
69.38
4.1
3.4
—
—
—
0
0
12615
70266
1.54
66.80
21.6
17.7
139.6
139.8
mmol/l
14.67
12345
68443
3582
16179
1.43
65.03
4.2
4.0
85.0
81.2
%
15.69
3520
15810
1819
7119
1.61
64.94
3.7
3.4
—
—
—
0
0
12629
70457
1.54
64.71
21.8
17.8
4.0
4.0
mmol/l
5.56
12344
68559
3799
17575
1.40
59.24
4.2
3.6
0.0
0.0
estimate
0.05
1386
5088
3672
16985
1.40
56.87
2.1
2.3
3.0
2.9
mg/l
0.88
3103
14355
12612
70816
1.48
54.80
24.2
16.9
91.0
89.9
umol/l
2.38
12607
70783
1322
4979
1.65
54.41
5.1
3.5
1.2
1.2
mmol/l
0.97
1158
4291
5893
29585
1.32
52.86
5.7
5.8
24.5
25.8
%
15.02
5423
27278
5721
28775
1.32
49.60
5.5
5.7
2.9
3.0
%
2.78
5287
26612
2315
10182
1.43
46.36
3.2
2.9
0.8
0.8
mmol/l
2.21
2192
9406
5757
29193
1.30
45.83
5.5
5.6
59.7
58.6
%
8.63
5329
27095
2187
9556
1.44
45.27
6.8
7.7
104.8
104.5
mmol/l
1.83
2159
9286
4704
23365
1.31
42.84
2.8
2.9
246.3
183.9
ug/l
12.94
4206
21346
5556
28217
1.29
42.76
12.1
9.0
0.0
0.0
e9/l
0.20
4642
23217
12757
72628
1.41
38.84
28.6
20.9
229.8
228.0
e9/l
2.48
12486
70250
12427
70445
1.38
38.75
12.3
9.4
26.7
28.7
u/l
11.12
11946
67504
12760
72673
1.40
38.40
28.6
20.9
6.8
6.9
e9/l
3.31
12446
69997
12759
72667
1.40
38.39
28.6
20.9
4.4
4.6
e12/l
181.89
12436
69976
12760
72677
1.40
38.33
28.7
21.0
134.9
140.5
g/l
247.92
12599
71307
306
784
2.37
38.06
2.9
1.9
155.0
1361.7
u/ml
0.85
276
705
268
653
2.49
37.07
1.3
1.3
—
—
—
0
0
1057
4174
1.56
35.27
7.6
11.5
—
—
—
0
0
4096
20521
1.27
32.74
2.6
2.4
59.3
61.8
u/l
1.31
3764
18911
1514
6553
1.43
32.18
2.8
2.5
8.5
9.5
umol/l
1.04
1343
5820
6050
31851
1.24
30.84
5.5
5.5
1.7
1.8
e9/l
1.86
5217
27653
6089
32181
1.23
29.44
5.5
5.6
0.2
0.2
e9/l
9.22
5221
27853
1186
4984
1.46
29.35
3.4
3.7
0.1
0.1
%
1.50
392
1150
305
874
2.12
29.29
3.2
3.0
1.8
1.5
%
0.45
213
648
1922
8797
1.36
29.18
2.5
2.1
1.8
1.7
%
0.84
1674
7703
2453
11710
1.31
27.78
1.9
1.8
—
—
—
0
0
1491
6598
1.40
27.75
2.8
2.2
67.9
67.9
e9/l
0.02
1158
5055
1210
5182
1.44
27.05
2.2
2.1
0.2
0.2
g/l
0.99
1110
4687
3984
20250
1.25
27.03
3.6
2.8
35.2
37.6
u/l
0.86
3761
19022
1122
4747
1.45
26.74
3.3
3.6
1.1
0.6
%
2.94
298
914
2358
11309
1.30
25.57
2.6
2.7
12.5
13.2
umol/l
4.22
2169
10446
2215
10535
1.31
25.56
2.6
2.7
2.2
2.2
g/l
3.61
2030
9722
9449
52626
1.22
25.13
24.0
17.0
13.8
13.7
%
12.93
9315
51296
2090
9919
1.31
24.40
2.7
2.8
23.0
23.7
%
1.31
1738
8383
3333
16771
1.25
24.24
1.6
1.6
18.4
18.9
nmol/l
1.12
2837
14418
10199
57351
1.22
23.81
20.3
15.7
38.9
40.5
%
31.10
6359
37532
1017
4318
1.44
23.73
1.6
1.6
—
—
—
0
0
8575
47455
1.20
23.46
3.9
3.9
14.4
11.7
mm/h
34.10
7735
43636
71
99
4.32
23.41
1.1
1.1
—
—
—
0
0
1800
8470
1.31
22.20
6.8
8.3
95.7
95.0
%
4.70
1702
8177
1627
7570
1.32
21.71
7.2
9.0
121.5
125.0
g/l
9.33
1549
7320
776
3183
1.49
21.57
2.0
2.0
3.6
2.1
ug/l
1.16
671
2824
956
4103
1.42
21.00
8.3
10.8
23.8
24.3
mmol/l
4.92
904
3724
66
98
4.05
20.23
5.7
1.1
36.4
156.8
u/ml
0.50
22
14
248
758
1.98
20.22
1.5
1.2
—
—
—
0
0
1920
9239
1.28
19.86
6.6
8.0
0.5
1.1
mmol/l
7.88
1480
7178
1443
6691
1.33
19.62
6.7
8.0
1.4
1.5
mmol/l
1.39
1387
6428
1914
9238
1.28
19.29
6.6
8.0
12.2
11.4
kpa
9.44
1799
8815
1913
9245
1.28
19.07
6.6
8.0
5.1
5.0
kpa
2.06
1795
8825
1891
9128
1.28
19.02
6.1
6.7
1.0
1.0
mmol/l
0.41
1760
8510
699
2917
1.46
17.82
2.0
1.8
—
—
—
0
0
178
512
2.10
17.13
1.5
1.2
97.0
55.0
u/l
1.96
128
315
645
2680
1.46
16.83
1.9
1.7
—
—
—
0
0
190
586
1.96
15.23
3.2
3.0
60.2
62.6
%
0.54
108
375
18
0
+∞
15.21
1.1
0.0
—
—
—
0
0
2356
11938
1.22
15.09
2.0
2.0
30.3
30.4
s
0.39
2289
11595
1289
6132
1.29
14.37
2.7
1.7
65.7
66.9
g/l
6.38
1164
5581
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
622
2661
1.42
13.93
2.8
3.1
0.4
0.3
u/ml
1.09
350
1568
946
4334
1.33
13.89
6.3
8.6
24.3
24.6
mmol/l
1.28
940
4284
4449
23983
1.16
13.77
3.0
3.2
1878.9
1688.8
ng/l
1.27
3840
20849
1812
9033
1.23
13.49
4.7
5.0
31.3
31.5
%
0.37
1175
6271
1218
5807
1.28
13.33
3.2
2.5
64.4
62.5
ml/min/173m2
0.82
484
2215
102
261
2.35
13.04
1.5
1.3
4.3
4.3
mg/l
0.04
93
253
5357
29366
1.15
12.94
4.0
4.0
54.0
96.4
ng/l
3.47
4346
22660
935
4324
1.32
12.86
1.8
1.6
—
—
—
0
0
746
3352
1.35
12.48
4.3
5.1
0.9
0.9
%
0.17
680
3176
4091
22055
1.16
12.35
2.0
2.1
78.7
75.6
nmol/l
9.09
3543
19379
754
3417
1.34
11.93
4.2
5.0
1.6
1.7
%
2.62
685
3242
1100
5252
1.28
11.89
2.3
2.4
35.4
43.7
u/l
1.20
921
4463
215
752
1.73
11.73
1.1
1.1
—
—
—
0
0
106
290
2.20
11.70
1.9
1.5
7.6
5.5
u/l
0.63
53
125
2749
14427
1.18
11.64
4.3
3.6
1.0
1.0
kg/l
0.52
445
2105
96
255
2.27
11.36
1.2
1.1
20.7
24.1
u/l
0.34
58
192
416
1722
1.46
11.18
4.1
4.7
2.2
2.4
mmol/l
1.24
266
1139
416
1723
1.46
11.15
4.1
4.7
4.9
5.0
kpa
1.61
409
1674
95
255
2.24
10.99
1.2
1.1
69.7
92.5
u/l
2.04
62
203
1047
5017
1.27
10.99
8.5
10.5
0.6
0.7
%
12.73
1038
4981
109
310
2.12
10.98
1.3
1.4
—
—
—
0
0
1097
8096
0.80
10.85
1.8
1.9
1.7
1.6
%
0.43
903
6880
799
3704
1.31
10.82
1.5
1.5
1.6
1.5
g/l
2.95
679
3153
1484
7409
1.22
10.79
6.9
8.0
11.5
11.3
mmol/l
0.40
1408
7015
2689
14188
1.17
10.54
1.8
1.8
1129.3
1128.2
nmol/l
0.02
1974
10820
374
1537
1.47
10.45
1.5
1.5
—
—
—
0
0
376
1551
1.47
10.32
1.4
1.4
—
—
—
0
0
5354
29668
1.13
10.24
2.0
2.0
93.2
91.6
pmol/l
1.69
3074
17012
1045
5054
1.26
10.15
8.4
10.3
1.2
1.4
%
5.84
1037
5014
417
1762
1.43
10.10
5.4
7.1
105.0
105.1
mmol/l
0.18
358
1620
87
234
2.24
10.06
2.9
3.1
—
—
—
0
0
1611
8166
1.21
10.03
1.8
1.7
—
—
—
0
0
397
1668
1.44
9.92
2.4
2.6
16.0
16.8
%
2.53
225
919
282
1106
1.54
9.86
1.6
1.6
—
—
—
0
0
359
1490
1.46
9.58
1.5
1.6
—
—
—
0
0
1047
5108
1.25
9.43
3.5
3.6
1.6
1.6
mmol/l
0.05
748
3679
1093
5371
1.24
9.23
3.6
3.7
5.1
5.1
kpa
0.16
1001
4961
418
3430
0.72
9.17
1.6
1.7
44.2
44.1
nmol/l
0.05
404
3302
864
4137
1.27
9.14
1.6
1.5
—
—
—
0
0
426
1846
1.40
9.00
2.8
3.0
7.8
7.9
kpa
0.09
397
1717
76
206
2.22
8.70
1.9
1.4
—
—
—
0
0
1596
8198
1.19
8.55
1.9
1.8
—
—
—
0
0
93
277
2.02
8.43
1.8
1.4
—
—
—
0
0
93
278
2.01
8.35
1.8
1.4
—
—
—
0
0
93
278
2.01
8.35
1.8
1.4
—
—
—
0
0
93
278
2.01
8.35
1.8
1.4
—
—
—
0
0
524
2383
1.33
8.20
2.9
1.6
3.8
2.6
ratio
0.43
42
187
74
205
2.17
8.07
1.9
1.4
—
—
—
0
0
74
206
2.16
7.99
1.9
1.4
—
—
—
0
0
11332
66020
1.13
7.95
5.0
5.1
6.1
6.2
mmol/l
10.45
10005
59956
7293
41509
1.11
7.85
3.2
3.1
57.9
57.5
u/l
0.12
6636
38148
419
1860
1.36
7.71
1.3
1.3
—
—
—
0
0
11
316
0.21
7.61
18.2
15.8
1513.2
1343.6
nmol/l
0.39
11
302
533
2458
1.31
7.59
2.9
1.6
73.2
39.4
mg/l
0.70
411
1970
349
1511
1.39
7.49
1.7
1.6
—
—
—
0
0
533
2463
1.31
7.49
2.9
1.6
66.7
54.1
mg/l
0.62
408
1974
750
3619
1.26
7.48
4.2
4.5
23.7
23.9
mmol/l
0.82
666
3178
10
301
0.20
7.44
13.9
11.6
1077.3
812.6
nmol/l
—
10
284
15
15
6.00
7.00
10.6
4.3
0.3
0.3
umol/l
—
15
8
9851
57093
1.11
6.92
3.7
3.7
2.5
2.2
mu/l
0.52
8569
51173
27
47
3.45
6.91
1.2
1.1
—
—
—
0
0
4353
28035
0.90
6.89
4.0
4.2
9.2
9.3
mg/mmol
0.04
2856
19378
180
697
1.56
6.81
1.4
1.3
—
—
—
0
0
176
682
1.55
6.65
2.4
2.9
—
—
—
0
0
91
294
1.86
6.64
1.8
1.2
106.8
102.2
u/l
0.10
79
249
251
1048
1.44
6.64
1.5
1.5
31.9
30.9
g/l
0.56
208
932
180
702
1.54
6.62
1.4
1.3
537.0
459.1
u/l
0.17
168
660
249
2100
0.71
6.57
1.2
1.4
—
—
—
0
0
880
4393
1.21
6.44
2.5
1.8
368.7
358.8
nmol/l
0.61
819
3995
145
541
1.61
6.43
1.8
1.9
2.1
1.4
u/field
0.53
63
222
1439
7513
1.16
6.31
4.1
4.1
1.6
1.7
mmol/l
0.53
1151
6084
280
1205
1.40
6.30
1.8
2.0
1.8
1.8
mmol/l
0.24
273
1175
274
2258
0.72
6.29
1.2
1.4
—
—
—
0
0
86
278
1.86
6.29
1.9
1.2
32.1
26.2
u/l
0.29
74
234
176
694
1.53
6.19
1.4
1.3
—
—
—
0
0
176
694
1.53
6.19
1.4
1.3
—
—
—
0
0
113
1101
0.61
6.13
3.5
4.7
324.5
350.4
umol/l
1.24
87
922
4125
26509
0.91
6.07
3.2
3.4
320.0
253.3
mg/l
0.52
2723
18456
177
703
1.52
6.03
1.4
1.3
—
—
—
0
0
181
723
1.51
6.01
1.4
1.3
—
—
—
0
0
183
735
1.50
5.93
1.5
1.7
—
—
—
0
0
174
692
1.51
5.91
1.4
1.3
—
—
—
0
0
663
3245
1.24
5.90
3.9
4.0
24.6
24.6
mmol/l
0.05
602
2985
113
405
1.68
5.89
1.5
1.3
—
—
—
0
0
177
707
1.51
5.89
1.4
1.4
6.2
6.5
mmol/l
0.51
150
646
1434
7526
1.16
5.87
4.1
4.1
5.8
5.8
kpa
1.57
1402
7302
18
26
4.16
5.87
1.0
1.0
—
—
—
0
0
540
2585
1.26
5.85
2.5
2.9
—
—
—
0
0
111
397
1.68
5.83
1.5
1.3
—
—
—
0
0
103
361
1.72
5.82
1.7
1.8
2.5
2.5
u/field
0.04
71
259
145
559
1.56
5.67
1.3
1.3
15.2
13.5
u/l
0.24
132
518
108
388
1.67
5.60
1.4
1.4
—
—
—
0
0
217
1814
0.71
5.50
1.3
1.5
1.0
0.8
nmol/l
1.59
185
1493
77
253
1.83
5.42
1.8
2.1
22.4
17.1
%
1.10
25
101
201
839
1.44
5.41
1.5
1.5
57727.8
65762.6
e6/l
0.16
124
515
73
237
1.85
5.34
1.8
2.1
—
—
—
0
0
4174
26680
0.91
5.32
3.1
3.4
8.3
8.6
mmol/l
2.91
3333
22453
218
928
1.41
5.29
1.5
1.5
2049.6
3918.3
e6/l
0.87
154
681
253
1106
1.38
5.26
4.1
7.2
5406.4
967.9
iu/ml
0.44
30
193
251
1097
1.38
5.23
5.9
6.2
11.9
11.6
mg/l
0.58
235
1010
140
547
1.54
5.21
1.5
1.4
—
—
—
0
0
250
1099
1.37
5.05
3.3
3.3
59.5
59.3
%
0.07
250
1099
105
388
1.63
4.95
1.4
1.4
—
—
—
0
0
206
880
1.41
4.93
1.9
2.2
24.7
27.2
mg/l
0.20
52
247
460
2209
1.26
4.91
1.9
1.8
—
—
—
0
0
136
536
1.53
4.89
1.6
1.3
—
—
—
0
0
136
536
1.53
4.89
1.6
1.3
—
—
—
0
0
136
536
1.53
4.89
1.6
1.3
—
—
—
0
0
1323
8963
0.87
4.87
1.2
1.2
32.0
45.0
iu/ml
1.92
367
2686
2154
11750
1.12
4.84
27.5
29.4
1.5
1.5
inr
0.54
336
1544
22
332
0.40
4.72
1.1
1.3
—
—
—
0
0
1205
8179
0.87
4.57
2.4
2.5
7.2
9.5
ug/l
3.00
1032
7295
464
2255
1.24
4.50
3.0
3.2
24.5
24.5
mmol/l
0.01
406
2001
71
243
1.76
4.46
1.7
1.9
—
—
—
0
0
41
116
2.12
4.42
1.6
2.4
—
—
—
0
0
153
634
1.45
4.37
1.6
1.5
—
—
—
0
0
618
4389
0.84
4.23
2.0
2.0
—
—
—
0
0
210
926
1.37
4.23
1.5
1.6
—
—
—
0
0
341
2570
0.79
4.21
2.2
2.3
99.2
132.7
ug/min
0.76
187
1572
88
826
0.64
4.20
1.4
1.2
1.4
1.4
nmol/l
0.02
79
751
75
266
1.69
4.19
2.8
2.0
600.7
438.4
e6/l
0.64
64
229
17
270
0.38
4.15
18.2
13.4
0.7
0.7
mmol/l
0.10
17
242
57
187
1.83
4.13
1.5
1.9
2580.2
14775.1
u/ml
—
5
30
428
3138
0.81
4.11
1.3
1.3
387.4
312.1
u/ml
0.45
398
2934
13
233
0.33
4.11
2.2
2.8
122.4
136.6
nmol/l
0.27
13
203
230
1815
0.76
4.09
1.4
1.7
3.3
4.3
mg/l
0.80
168
1272
328
2474
0.79
4.09
1.8
1.9
179.9
198.9
pmol/l
1.99
300
2323
40
117
2.05
4.01
2.1
1.4
47.2
35.3
u/l
0.17
34
105
269
1242
1.30
4.00
1.3
1.5
—
—
—
0
0
152
1272
0.71
4.00
1.1
1.1
67.3
213.1
iu/ml
0.54
36
251
241
1097
1.32
3.97
1.3
1.3
—
—
—
0
0
8
5
9.60
3.94
1.0
1.0
—
—
—
0
0
116
465
1.50
3.94
1.4
1.4
—
—
—
0
0
495
2459
1.21
3.94
2.3
1.6
1.3
0.5
g/l
3.26
418
2112
193
851
1.36
3.92
2.1
3.0
582.3
11237.6
u/ml
0.48
16
50
788
4083
1.17
3.89
2.7
2.1
10.7
11.3
g/l
2.07
707
3716
232
1814
0.76
3.88
1.5
1.6
24.9
3.8
iu/ml
0.50
58
418
382
1850
1.24
3.88
2.2
2.2
126.9
134.0
g/l
5.16
297
1362
142
596
1.43
3.84
1.7
1.5
—
—
—
0
0
134
557
1.45
3.82
1.4
1.4
12.2
13.5
u/l
1.66
128
534
220
997
1.33
3.76
1.3
1.5
—
—
—
0
0
10959
64415
1.08
3.76
6.4
6.8
40.6
41.4
mmol/mol
12.56
9882
59513
276
2101
0.78
3.75
1.6
1.6
19470.2
15813.8
e6/l
0.53
194
1556
216
977
1.33
3.74
1.3
1.3
—
—
—
0
0
25
62
2.42
3.66
1.0
1.3
—
—
—
0
0
248
1901
0.78
3.58
1.1
1.2
0.2
0.6
u/ml
1.90
19
170
84
322
1.57
3.53
2.6
2.0
535.2
676.4
e6/l
1.22
41
137
577
2944
1.18
3.48
2.0
1.4
—
—
—
0
0
577
2944
1.18
3.48
2.0
1.4
7.4
7.4
g/l
0.31
417
2212
575
2933
1.18
3.48
2.0
1.4
4.0
4.0
g/l
0.07
403
2127
69
254
1.63
3.43
2.9
2.0
0.3
0.2
e9/l
0.37
63
228
832
4375
1.15
3.41
4.2
4.9
106.9
109.3
ng/l
0.25
716
3795
111
457
1.46
3.37
1.5
2.0
—
—
—
0
0
44
143
1.85
3.35
3.3
2.0
—
—
—
0
0
2753
15460
1.08
3.32
1.8
1.7
23949798.8
33069350.4
pmol/l
0.45
2213
12734
78
299
1.57
3.30
1.2
1.3
—
—
—
0
0
78
299
1.57
3.30
1.2
1.3
—
—
—
0
0
80
309
1.56
3.28
1.6
1.3
—
—
—
0
0
80
309
1.56
3.28
1.6
1.3
—
—
—
0
0
11560
68204
1.08
3.20
5.3
5.6
2.6
2.5
mmol/l
5.52
10287
62964
362
1784
1.22
3.20
3.6
3.3
7.3
8.0
mmol/l
5.34
353
1747
537
2746
1.18
3.19
2.1
1.5
10.2
10.5
g/l
0.57
444
2326
379
1880
1.21
3.14
3.5
3.2
1.7
1.7
mmol/l
0.46
370
1837
30
341
0.53
3.09
1.1
2.1
—
—
—
0
0
261
1255
1.25
2.92
1.4
1.3
—
—
—
0
0
75
668
0.67
2.91
1.1
1.1
3.5
1.8
iu/ml
—
7
25
1144
6207
1.11
2.88
3.2
3.3
4.5
4.6
kpa
0.23
1115
5984
1247
8209
0.90
2.87
1.2
1.2
11.3
14.7
u/ml
0.84
398
3029
222
1050
1.27
2.86
2.7
2.4
4.1
4.1
mmol/l
0.44
216
1042
222
1050
1.27
2.86
2.7
2.4
105.9
105.8
mmol/l
0.08
216
1041
65
252
1.55
2.69
2.3
2.7
27.5
38.8
%
2.75
22
89
5399
31240
1.06
2.59
2.1
2.1
—
—
—
0
0
11293
66714
1.07
2.57
4.7
5.0
4.4
4.3
mmol/l
14.39
10121
61887
155
711
1.31
2.56
1.4
1.3
0.6
2.1
nmol/l
0.48
148
688
529
2758
1.16
2.53
2.1
1.5
3.1
3.0
g/l
1.37
408
2179
307
1530
1.21
2.51
1.5
1.3
—
—
—
0
0
155
714
1.31
2.50
1.4
1.3
0.1
0.2
nmol/l
0.73
14
62
307
1531
1.21
2.49
1.5
1.3
—
—
—
0
0
16
40
2.40
2.38
6.5
1.2
—
—
—
0
0
233
1705
0.82
2.36
1.5
1.6
—
—
—
0
0
43
406
0.63
2.28
1.1
2.0
—
—
—
0
0
97
423
1.38
2.27
3.4
3.8
—
—
—
0
0
76
641
0.71
2.27
1.2
1.1
6.6
8.7
au/ml
—
7
30
10864
64183
1.06
2.25
4.2
4.4
1.3
1.3
mmol/l
4.79
9568
58745
74
626
0.71
2.25
1.0
1.1
0.6
1.4
u/ml
1.32
28
262
438
2275
1.16
2.25
2.1
1.5
37.0
37.4
g/l
0.77
371
1966
6
7
5.14
2.23
11.2
1.0
—
—
—
0
0
988
5400
1.10
2.23
6.5
7.6
24.5
24.4
mmol/l
0.24
906
5068
42
396
0.64
2.22
1.0
1.1
0.8
3.1
u/ml
2.06
11
161
9
130
0.41
2.15
2.0
2.4
—
137.9
—
0
17
323
1644
1.18
2.15
3.3
3.4
31.9
28.6
mg/l
0.88
202
1099
34
119
1.72
2.15
1.8
1.7
85.1
116.4
ug/l
1.08
28
96
11184
66165
1.06
2.11
4.7
4.9
1.3
1.3
mmol/l
25.34
9946
60924
2367
13439
1.07
2.10
1.6
1.8
1.7
1.3
mg/l
3.08
1854
10573
54
214
1.52
2.10
1.2
1.4
3.8
3.7
mmol/l
0.02
46
192
86
700
0.74
2.09
1.0
1.0
36.0
41.2
ng/l
0.75
64
475
86
700
0.74
2.09
1.0
1.0
687.3
727.1
ng/l
0.45
63
470
425
2218
1.15
2.07
2.2
1.5
0.1
0.0
g/l
0.95
390
2020
19
55
2.07
2.07
1.6
1.3
—
—
—
0
0
86
698
0.74
2.05
1.0
1.0
275.2
305.1
ng/l
0.65
66
484
238
1709
0.83
2.03
1.7
1.8
10.7
11.4
mg/l
0.73
215
1598
107
840
0.76
2.03
2.0
2.3
704.0
695.2
ml
0.07
58
563
21
64
1.97
2.02
3.6
1.6
42.7
53.7
u/l
—
6
26
54
217
1.49
1.99
1.3
1.3
125.3
34.3
ug/l
0.55
26
93
1285
7151
1.09
1.98
2.7
3.1
243.1
254.8
ng/l
0.33
1168
6582
68
567
0.72
1.94
1.1
1.2
78.1
146.0
titre
1.31
16
95
204
1476
0.83
1.91
1.3
1.3
—
—
—
0
0
5
6
5.00
1.89
1.0
1.0
—
—
—
0
0
28
277
0.61
1.87
1.1
1.0
—
—
—
0
0
26
88
1.77
1.86
2.2
2.1
—
—
—
0
0
985
5436
1.09
1.86
2.1
2.4
151.7
172.9
ug/g
0.81
758
4346
20
62
1.94
1.85
1.0
1.1
5.7
17.0
iu/ml
—
7
22
120
560
1.29
1.85
1.4
1.3
—
—
—
0
0
26
89
1.75
1.80
2.2
2.2
—
—
—
0
0
10
23
2.61
1.76
1.2
1.7
1.6
0.8
u/field
—
5
13
34
315
0.65
1.73
1.0
1.0
0.3
0.3
u/ml
—
9
83
131
980
0.80
1.73
1.4
1.4
52.5
107.9
pmol/l
1.00
70
285
399
2712
0.88
1.72
1.6
1.8
37.8
37.6
u/l
0.05
338
2311
391
2062
1.14
1.70
2.2
1.5
0.0
0.0
g/l
0.80
357
1868
44
176
1.50
1.70
1.4
1.4
17.4
27.6
%
1.54
34
143
384
2025
1.14
1.68
2.2
1.5
0.0
0.0
g/l
0.00
354
1862
197
1408
0.84
1.66
1.3
1.3
46.9
18.7
e6/l
0.38
142
1098
198
1410
0.84
1.61
1.4
1.4
536.3
1494.2
e6/l
1.42
152
1165
344
1807
1.15
1.61
1.8
2.2
88.5
85.1
%
2.24
328
1708
162
1174
0.83
1.60
1.1
1.1
3.6
9.8
u/ml
1.44
13
108
359
2432
0.88
1.51
1.4
1.4
—
—
—
0
0
269
1398
1.16
1.48
2.2
1.2
39.8
23.6
u/l
1.14
228
1199
34
303
0.67
1.48
1.2
1.3
65.0
60.7
%
0.31
29
265
84
647
0.78
1.47
1.1
1.1
—
—
—
0
0
7343
43206
1.04
1.45
3.0
2.9
15.0
14.9
pmol/l
1.56
6377
38360
45
188
1.44
1.45
1.3
1.1
3.4
2.2
u/l
0.19
11
24
118
871
0.81
1.43
1.3
1.3
162977.1
146943.7
e6/l
0.10
83
618
55
239
1.38
1.43
1.3
1.4
2.2
2.8
%
0.25
45
190
9
23
2.35
1.41
1.0
1.1
—
—
—
0
0
399
2670
0.89
1.39
4.6
4.9
3.9
4.0
mmol/l
0.86
371
2499
53
231
1.38
1.37
1.2
1.7
—
—
—
0
0
62
491
0.76
1.36
1.2
1.3
1.3
1.3
nmol/l
0.16
50
358
2585
14908
1.05
1.34
3.9
4.2
791.8
830.7
ng/l
0.04
2227
12905
182
1280
0.85
1.33
1.3
1.3
—
—
—
0
0
24
224
0.64
1.33
1.1
1.1
—
—
—
0
0
15
48
1.87
1.32
3.7
1.2
—
—
—
0
0
62
279
1.33
1.32
1.4
1.4
65.1
65.4
%
0.03
48
219
245
1681
0.87
1.30
1.5
1.6
—
—
—
0
0
402
2675
0.90
1.29
1.6
1.6
112.9
275.1
titre
2.62
14
108
344
1841
1.12
1.27
1.9
2.4
3.8
3.6
g/l
0.72
324
1758
29
114
1.53
1.27
1.4
1.4
9.6
7.8
%
0.25
15
48
136
975
0.83
1.26
1.1
1.1
—
—
—
0
0
178
1247
0.85
1.26
1.2
1.1
—
—
—
0
0
697
3867
1.08
1.25
2.8
2.9
1.2
1.3
%
0.46
689
3849
249
1699
0.88
1.23
1.2
1.4
0.2
0.2
g/l
0.48
236
1616
152
769
1.19
1.22
3.2
3.8
—
—
—
0
0
303
1614
1.13
1.22
2.2
2.5
209.8
200.0
%
1.06
289
1529
150
1062
0.85
1.22
1.7
1.8
262.9
257.4
mu/l
0.12
144
992
95
460
1.24
1.19
1.3
1.2
2.2
2.2
mmol/l
0.13
89
428
40
329
0.73
1.17
8.4
7.8
—
—
—
0
0
11
33
2.00
1.16
3.9
1.4
—
—
—
0
0
677
3767
1.08
1.16
2.8
2.9
0.6
0.7
%
1.04
641
3609
66
307
1.29
1.15
1.7
1.3
11.6
10.3
iu/l
0.31
53
247
65
497
0.78
1.14
1.1
1.1
—
—
—
0
0
26
103
1.51
1.12
1.4
1.5
—
—
—
0
0
910
5126
1.07
1.12
3.5
3.5
127.1
132.5
g/l
9.24
887
5005
529
3443
0.92
1.11
1.6
1.5
20.5
17.3
u/ml
0.12
14
83
23
89
1.55
1.10
1.3
1.4
32.0
42.3
u/l
0.33
16
65
113
811
0.83
1.10
2.5
2.2
—
0.4
—
0
7
31
129
1.44
1.07
1.4
1.2
54.6
67.0
mu/l
0.20
24
89
112
560
1.20
1.06
1.3
1.4
279.6
280.5
mosm/kgh2o
0.11
84
425
24
95
1.52
1.05
1.1
1.1
—
—
—
0
0
38
166
1.37
1.02
1.1
1.2
—
—
—
0
0
9
97
0.56
1.02
1.0
1.0
—
—
—
0
0
37
300
0.74
1.02
1.1
1.1
1.1
1.1
ratio
0.17
12
89
260
1742
0.89
1.01
1.2
1.4
1.2
1.2
g/l
0.07
249
1658
11
36
1.83
0.94
1.0
1.1
5.9
6.0
mmol/l
0.04
11
24
77
377
1.23
0.93
1.5
1.4
3.7
4.1
%
0.14
18
93
28
232
0.72
0.90
1.0
1.1
—
9.1
u/ml
—
0
16
21
84
1.50
0.90
1.0
1.1
—
—
—
0
0
223
1494
0.89
0.89
1.6
1.3
7.8
6.4
u/l
1.43
174
1206
13
46
1.70
0.89
1.5
1.5
0.7
0.6
umol/l
—
6
40
18
70
1.54
0.87
1.1
1.2
—
—
—
0
0
71
518
0.82
0.87
1.1
1.2
10.9
12.3
mmol/l
0.79
22
186
22
90
1.47
0.86
3.1
2.5
0.2
0.2
u/field
0.11
22
90
186
989
1.13
0.85
5.9
14.5
7.1
7.7
mmol/l
1.99
158
803
104
729
0.85
0.83
1.5
2.1
768.0
3690.0
titre
—
5
40
304
1664
1.10
0.83
1.4
1.5
256.7
265.6
ug/g
0.29
182
1012
0
17
0.00
0.81
0.0
6.0
—
0.3
—
0
17
46
348
0.79
0.80
1.3
1.2
—
—
—
0
0
6
19
1.89
0.80
1.0
1.4
—
—
—
0
0
7
77
0.54
0.80
1.9
2.0
14.5
16.8
umol/l
—
7
77
685
3877
1.06
0.80
4.4
4.1
46.8
48.0
%
0.63
676
3827
21
87
1.45
0.79
1.2
1.1
—
—
—
0
0
735
4177
1.06
0.76
3.8
3.5
25.0
25.0
mmol/l
0.20
709
4048
108
748
0.86
0.76
1.2
1.1
7.4
7.6
mmol/l
0.28
82
519
1556
9008
1.04
0.75
1.5
1.3
2.8
3.0
g/l
4.41
933
5395
103
714
0.86
0.74
1.2
1.4
1.2
1.5
promille
0.95
87
547
13
49
1.59
0.73
1.2
1.4
—
—
—
0
0
337
2183
0.92
0.72
1.4
1.5
7.3
9.8
iu/ml
—
7
49
91
467
1.17
0.72
1.1
1.2
—
—
—
0
0
5
15
2.00
0.72
1.8
1.1
1121.5
537.5
nmol/l
—
5
15
93
647
0.86
0.71
1.1
1.1
—
—
—
0
0
116
794
0.88
0.71
1.1
1.2
110.8
109.5
%
0.17
100
716
41
308
0.80
0.70
2.0
2.4
52.7
56.0
umol/l
0.43
30
254
27
214
0.76
0.70
1.2
1.7
12.6
13.3
g/l
0.15
19
161
90
626
0.86
0.69
1.1
1.2
91.3
96.9
%
1.17
79
582
31
142
1.31
0.68
11.1
11.1
5.4
5.6
mmol/l
0.16
31
142
179
967
1.11
0.67
1.3
1.2
—
—
—
0
0
85
592
0.86
0.67
1.2
1.2
166.8
192.4
miu/ml
0.21
17
136
10
36
1.67
0.66
1.3
1.4
—
—
—
0
0
53
261
1.22
0.66
1.8
1.6
0.3
0.3
mmol/l
0.00
48
248
1614
9983
0.97
0.64
1.2
1.2
1.8
2.2
u/ml
0.42
393
2665
248
1617
0.92
0.64
1.3
1.3
611.7
583.8
mg/l
0.28
232
1541
1553
9602
0.97
0.61
7.8
7.5
—
—
—
0
0
32
150
1.28
0.61
1.3
1.2
280.4
270.0
pmol/l
0.06
21
110
217
1418
0.92
0.60
1.2
1.2
3.8
4.0
mmol/l
1.92
201
1340
11
42
1.57
0.60
1.1
1.1
1.8
2.1
umol/24h
0.41
11
42
319
1782
1.08
0.60
2.9
2.8
1.9
1.8
mg/l
0.74
282
1580
14
57
1.47
0.59
1.1
1.0
—
—
—
0
0
148
799
1.11
0.59
1.9
1.3
236.6
246.4
pmol/l
0.22
108
576
34
162
1.26
0.58
1.9
2.8
6.9
8.4
mmol/l
2.04
22
94
5
54
0.56
0.58
1.0
1.2
0.1
0.1
nmol/l
—
5
40
36
173
1.25
0.58
1.1
1.1
—
—
—
0
0
29
220
0.79
0.57
1.1
1.1
97.0
100.8
%
0.20
22
176
32
152
1.26
0.56
1.1
1.1
—
—
—
0
0
192
1055
1.09
0.55
1.6
1.5
61.6
62.6
%
0.11
127
704
23
178
0.77
0.54
1.2
1.3
0.3
0.3
g/l
0.57
17
143
131
869
0.90
0.52
1.1
1.1
1.5
1.6
g/l
0.20
119
782
239
1543
0.93
0.52
1.2
1.2
123.5
108.7
titre
0.10
23
141
489
3085
0.95
0.52
4.1
4.5
1.4
1.4
mmol/l
0.68
474
3025
55
280
1.18
0.52
2.3
2.4
—
—
—
0
0
55
280
1.18
0.52
2.3
2.4
—
—
—
0
0
57
399
0.86
0.52
1.7
1.3
8.4
6.1
u/l
0.41
49
344
62
320
1.16
0.51
1.3
1.2
—
—
—
0
0
382
2164
1.06
0.51
3.2
3.1
4.5
4.4
pmol/l
0.30
339
1933
43
215
1.20
0.50
1.3
1.2
—
—
—
0
0
55
384
0.86
0.49
1.1
1.1
5.4
7.1
nmol/l
0.26
14
81
69
361
1.15
0.48
1.0
1.1
—
—
—
0
0
71
485
0.88
0.48
2.2
2.2
64.4
171.1
ug/min
1.36
23
132
40
286
0.84
0.48
3.5
5.6
72.3
71.5
%
0.07
33
245
53
272
1.17
0.47
1.1
1.2
—
—
—
0
0
51
356
0.86
0.46
1.1
1.1
—
—
—
0
0
51
356
0.86
0.46
1.1
1.1
—
—
—
0
0
62
323
1.15
0.46
1.3
1.2
—
—
—
0
0
125
824
0.91
0.46
1.2
1.3
3.5
4.2
u/ml
0.30
54
401
36
179
1.21
0.45
1.0
1.1
—
—
—
0
0
18
82
1.32
0.44
1.6
1.6
37.9
44.2
umol/l
0.55
18
82
191
1233
0.93
0.44
1.1
1.2
3.6
8.1
u/ml
—
9
127
18
139
0.78
0.43
1.2
1.8
1.2
1.2
mmol/l
0.65
18
134
52
359
0.87
0.42
1.1
1.1
—
—
—
0
0
52
359
0.87
0.42
1.1
1.1
—
—
—
0
0
0
11
0.00
0.42
0.0
1.2
—
—
—
0
0
10
84
0.71
0.41
1.0
1.1
—
—
—
0
0
52
358
0.87
0.41
1.1
1.1
—
—
—
0
0
80
535
0.90
0.41
1.0
1.1
—
—
—
0
0
293
1855
0.95
0.40
2.1
2.8
30.4
34.0
umol/l
2.09
235
1579
54
369
0.88
0.39
1.1
1.2
—
—
—
0
0
131
852
0.92
0.39
1.2
1.3
4.7
4.2
u/ml
0.11
51
312
195
1248
0.94
0.38
1.1
1.2
3.4
8.1
u/ml
1.78
14
189
238
1512
0.94
0.37
1.6
1.7
—
—
—
0
0
3131
18520
1.02
0.37
1.7
1.7
1.3
1.4
mmol/l
1.68
2472
15182
29
145
1.20
0.37
1.5
1.2
8.7
11.8
u/l
0.63
24
96
20
96
1.25
0.36
1.0
1.1
—
—
—
0
0
55
372
0.89
0.35
2.0
2.1
—
—
—
0
0
31
219
0.85
0.35
1.1
1.1
—
—
—
0
0
95
623
0.91
0.35
1.5
1.4
—
—
—
0
0
6
26
1.38
0.35
2.3
1.5
0.8
1.8
%
—
6
26
13
101
0.77
0.34
1.2
1.4
75.2
71.9
%
0.63
13
96
16
75
1.28
0.34
1.1
1.1
—
—
—
0
0
13
59
1.32
0.34
1.1
1.1
14.9
8.5
u/l
0.57
13
59
15
114
0.79
0.34
1.2
1.2
47.5
50.2
%
—
6
39
6
27
1.33
0.34
1.0
1.0
250.2
233.8
nmol/l
—
6
27
32
224
0.86
0.33
1.1
1.3
214.6
146.5
nmol/l
0.59
24
168
13
100
0.78
0.32
1.2
1.4
376.1
941.2
mu/l
0.80
13
95
37
255
0.87
0.32
1.0
1.1
1.0
1.0
u/l
0.08
18
124
25
178
0.84
0.32
1.1
1.1
—
—
—
0
0
98
541
1.09
0.32
1.5
1.7
77.1
76.7
umol/l
—
7
29
27
190
0.85
0.31
1.1
1.2
—
—
—
0
0
127
816
0.93
0.30
1.1
1.1
—
—
—
0
0
25
126
1.19
0.30
1.2
1.2
—
—
—
0
0
82
450
1.09
0.30
1.0
1.1
—
—
—
0
0
509
3154
0.97
0.30
2.3
2.4
582.2
614.7
ug/l
0.09
492
3000
19
93
1.23
0.30
1.2
1.1
0.8
0.7
umol/24h
0.18
11
42
15
112
0.80
0.30
6.1
4.9
—
—
—
0
0
22
157
0.84
0.29
1.0
1.2
—
—
—
0
0
14
105
0.80
0.29
1.7
1.8
—
—
—
0
0
16
77
1.25
0.29
1.1
1.2
—
—
—
0
0
66
435
0.91
0.29
2.6
3.6
13.2
13.3
%
0.28
66
429
21
150
0.84
0.28
1.1
1.1
—
—
—
0
0
21
105
1.20
0.28
1.3
1.3
1.0
0.9
mmol/l
0.01
15
66
10
45
1.33
0.28
4.3
3.9
—
—
—
0
0
20
100
1.20
0.27
1.0
1.1
—
—
—
0
0
5
44
0.68
0.27
1.4
1.4
—
—
—
0
0
16
78
1.23
0.27
1.1
1.1
—
—
—
0
0
11
51
1.29
0.26
1.1
1.3
1.3
1.3
%
0.13
11
51
65
357
1.09
0.25
2.3
2.4
—
—
—
0
0
32
169
1.14
0.24
1.1
1.2
—
—
—
0
0
605
3539
1.03
0.24
1.3
1.3
63.1
50.3
au/ml
0.57
34
160
171
1076
0.95
0.23
1.1
1.2
1.1
7.1
u/ml
—
7
89
34
229
0.89
0.23
1.4
2.4
13486.8
6108.7
e6/l
0.27
22
124
61
336
1.09
0.23
1.1
6.2
56.5
2324.3
mg/l
1.34
44
249
57
372
0.92
0.22
1.4
1.3
1.3
1.5
g/l
—
5
30
40
216
1.11
0.22
1.2
1.0
—
—
—
0
0
0
7
0.00
0.22
0.0
1.1
—
70.7
—
0
7
32
215
0.89
0.21
1.1
1.1
—
—
—
0
0
157
987
0.95
0.21
1.5
1.6
107.9
115.4
u/ml
0.45
38
222
40
265
0.90
0.21
1.4
2.4
1091.5
2570.3
e6/l
0.39
32
191
270
1564
1.04
0.21
1.6
1.6
—
—
—
0
0
54
351
0.92
0.20
1.5
1.5
—
—
—
0
0
6
31
1.16
0.19
1.0
1.0
—
—
—
0
0
144
825
1.05
0.19
1.5
1.4
26.9
24.7
%
0.32
90
556
55
356
0.93
0.19
1.5
1.4
3.4
1.4
u/ml
0.50
30
213
91
578
0.94
0.19
1.7
1.6
38.3
28.5
u/ml
0.66
17
129
52
288
1.08
0.19
1.1
1.3
42.1
41.2
g/l
0.16
26
158
244
1417
1.03
0.18
1.2
1.2
—
—
—
0
0
11
54
1.22
0.18
1.0
1.1
—
—
—
0
0
8
40
1.20
0.17
1.1
1.1
—
—
—
0
0
190
1180
0.97
0.17
1.1
1.2
—
12.5
—
0
14
327
2010
0.98
0.16
1.1
1.1
116.1
105.9
iu/ml
0.19
100
699
34
222
0.92
0.15
1.5
1.3
39.1
35.0
%
0.23
27
142
14
97
0.87
0.15
1.6
2.9
—
—
—
0
0
72
456
0.95
0.15
1.0
1.1
281.3
275.2
mg/l
0.34
65
416
158
916
1.03
0.14
1.3
1.3
277.3
292.3
u/ml
0.28
98
602
48
270
1.07
0.13
1.1
1.1
538.1
669.0
ng/l
0.12
15
70
258
1511
1.02
0.13
1.2
1.2
—
—
—
0
0
25
164
0.91
0.12
1.3
1.5
11.6
9.6
ug/l
0.81
25
164
31
201
0.92
0.12
1.2
1.1
—
—
—
0
0
3916
23374
1.01
0.12
2.2
2.3
242.7
270.7
u/l
1.02
3667
21937
79
453
1.05
0.12
1.2
1.3
82.0
94.2
titre
—
5
40
51
323
0.95
0.11
1.1
1.1
—
—
—
0
0
256
1503
1.02
0.11
1.2
1.2
—
—
—
0
0
16
107
0.90
0.11
1.1
1.2
—
—
—
0
0
37
236
0.94
0.10
1.2
1.4
0.1
0.1
nmol/l
0.10
26
195
5
26
1.15
0.10
1.0
1.0
—
—
—
0
0
5
28
1.07
0.09
1.0
1.0
—
—
—
0
0
19
104
1.10
0.09
1.3
1.1
—
—
—
0
0
6
32
1.12
0.09
1.0
1.2
200.5
233.0
u/l
—
6
27
3582
21400
1.01
0.09
2.9
2.8
5904.7
5489.8
umol/l
0.17
3001
18473
6
34
1.06
0.08
1.2
1.5
—
—
—
0
0
36
228
0.95
0.08
1.1
1.0
23.0
10.0
iu/ml
—
7
56
154
903
1.02
0.08
1.5
1.5
—
—
—
0
0
30
169
1.06
0.08
1.1
1.2
—
—
—
0
0
22
142
0.93
0.08
1.2
1.3
—
—
—
0
0
16
105
0.91
0.08
1.4
1.4
83.0
84.9
%
—
7
51
25
160
0.94
0.07
1.6
1.8
116.6
148.5
ng/l
0.66
25
160
8
46
1.04
0.07
1.1
1.0
—
—
—
0
0
28
178
0.94
0.07
3.0
2.9
—
—
—
0
0
9
61
0.88
0.06
1.6
1.1
—
—
—
0
0
260
1580
0.99
0.06
2.9
2.8
0.8
0.8
nmol/l
0.03
187
1200
137
806
1.02
0.06
1.4
1.6
4.4
16.8
iu/l
0.48
34
246
18
116
0.93
0.06
1.9
1.1
66.3
81.1
%
—
8
69
30
171
1.05
0.06
1.0
1.2
11.6
11.9
umol/l
0.03
23
122
902
5440
0.99
0.05
1.2
1.2
—
—
—
0
0
69
425
0.97
0.05
1.3
1.4
14.5
15.2
umol/l
0.37
63
394
24
152
0.95
0.05
1.5
1.1
—
—
—
0
0
661
3941
1.01
0.04
2.4
2.4
42.0
24.8
au/ml
0.78
19
137
29
167
1.04
0.04
1.1
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
16
102
0.94
0.03
1.1
1.3
77.1
74.9
%
—
7
47
53
310
1.03
0.03
1.1
1.2
—
—
—
0
0
84
495
1.02
0.03
1.0
1.1
3.3
3.8
u/ml
0.11
27
188
19
108
1.06
0.03
1.1
1.2
—
—
—
0
0
52
319
0.98
0.03
1.0
1.1
—
—
—
0
0
10
55
1.09
0.03
1.1
1.1
—
—
—
0
0
12
77
0.93
0.02
1.1
1.1
—
—
—
0
0
12
77
0.93
0.02
1.8
1.4
0.8
0.9
ml/s/173m2
—
7
54
17
97
1.05
0.02
1.0
1.2
—
—
—
0
0
29
169
1.03
0.01
1.1
1.1
—
—
—
0
0
314
1891
1.00
0.01
1.2
1.3
—
—
—
0
0
12
76
0.95
0.01
1.2
1.1
—
—
—
0
0
46
272
1.01
0.00
1.4
1.6
62.3
93.0
umol/l
0.80
20
131
15
93
0.97
0.00
1.1
1.6
—
—
—
0
0
22
130
1.01
0.00
1.3
1.2
—
—
—
0
0
21
123
1.02
0.00
1.5
1.2
269.2
154.9
titre
—
5
9
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
56
333
1.01
0.00
1.1
1.1
—
—
—
0
0
51
305
1.00
0.00
1.1
1.1
—
—
—
0
0
14
81
1.04
0.00
1.1
1.0
—
—
—
0
0
29
175
0.99
0.00
1.2
1.4
—
—
—
0
0
20
119
1.01
0.00
1.2
1.1
81.7
81.5
%
—
10
71
20
118
1.02
0.00
1.3
1.2
5861.7
145.8
ng/l
—
10
84
48
290
0.99
0.00
1.2
1.2
81.5
50.7
%
—
6
22
10
59
1.02
0.00
1.1
1.1
—
—
—
0
0
57
345
0.99
0.00
1.1
1.1
348.1
332.8
mg/l
0.18
46
314
10
57
1.05
0.00
1.1
1.1
—
—
—
0
0
340
2040
1.00
0.00
1.0
1.1
—
—
—
0
0
61
366
1.00
0.00
1.1
1.1
52.0
46.6
mg/l
0.37
50
321
36
217
0.99
0.00
1.1
1.1
1427.5
1634.8
miu/ml
0.43
36
217
10
62
0.97
0.00
1.0
1.1
—
—
—
0
0
25
148
1.01
0.00
1.1
1.2
206.2
0.8
mg/l
0.48
19
110
25
148
1.01
0.00
1.2
1.2
1.6
1.3
mmol/l
1.04
18
83
7
43
0.98
0.00
2.0
2.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
45
0.93
0.00
1.1
1.1
6100.0
294.2
u/l
—
7
38
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
7
45
0.93
0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_PROSTATE_EXALLC – Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)
GWS hits: 116
This endpoint is excluded (different definition than used in FinnGen).